Asimadoline

N/A

Report date: 2025/07/01 20:00:14
NME

Base Information

Drug NameAsimadoline
Drug Alias Name阿西马多林asimadolina阿司马都林asimadolineasimadolinum +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor agonists
TargetsKappa opioid receptor
Therapy Area/IndicationsVasomotor symptomPruritusDermatitis, Atopic +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVasomotor symptom
Inactive IndicationsPruritusDermatitis, AtopicIleus +[4

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank